168 related articles for article (PubMed ID: 26886439)
21. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway.
Nossent JC; Gran JT
Scand J Rheumatol; 2009; 38(4):251-5. PubMed ID: 19247847
[TBL] [Abstract][Full Text] [Related]
22. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
[TBL] [Abstract][Full Text] [Related]
23. Malignancy development risk in psoriatic arthritis patients undergoing treatment: A systematic review and meta-analysis.
Luo X; Deng C; Fei Y; Zhang W; Li Y; Zhang X; Zhao Y; Zeng X; Zhang F
Semin Arthritis Rheum; 2019 Feb; 48(4):626-631. PubMed ID: 29929736
[TBL] [Abstract][Full Text] [Related]
24. Incidence and time trends of joint surgery in patients with psoriatic arthritis: a register-based time series and cohort study from Denmark.
Guldberg-Møller J; Cordtz RL; Kristensen LE; Dreyer L
Ann Rheum Dis; 2019 Nov; 78(11):1517-1523. PubMed ID: 31300461
[TBL] [Abstract][Full Text] [Related]
25. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study.
Egeberg A; Kristensen LE; Thyssen JP; Gislason GH; Gottlieb AB; Coates LC; Jullien D; Gisondi P; Gladman DD; Skov L; Mallbris L
Ann Rheum Dis; 2017 Sep; 76(9):1591-1597. PubMed ID: 28483767
[TBL] [Abstract][Full Text] [Related]
26. Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
Pérez-Plaza A; Carretero G; Ferrandiz C; Vanaclocha F; Gómez-García FJ; Herrera-Ceballos E; De la Cueva-Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Torrado R; Carrascosa JM; Llamas-Velasco M; Rivera R; Jiménez-Puya R; García-Doval I; Descalzo MA;
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1021-1028. PubMed ID: 28252811
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
28. Psoriatic arthritis treatment and the risk of herpes zoster.
Zisman D; Bitterman H; Shalom G; Feldhamer I; Comanesther D; Batat E; Greenberg-Dotan S; Cohen S; Cohen AD
Ann Rheum Dis; 2016 Jan; 75(1):131-5. PubMed ID: 25261573
[TBL] [Abstract][Full Text] [Related]
29. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study.
Eder L; Haddad A; Rosen CF; Lee KA; Chandran V; Cook R; Gladman DD
Arthritis Rheumatol; 2016 Apr; 68(4):915-23. PubMed ID: 26555117
[TBL] [Abstract][Full Text] [Related]
30. Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis.
Favarato MH; Mease P; Gonçalves CR; Gonçalves Saad C; Sampaio-Barros PD; Goldenstein-Schainberg C
Clin Exp Rheumatol; 2014; 32(2):182-7. PubMed ID: 24480317
[TBL] [Abstract][Full Text] [Related]
31. High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex.
Albrecht K; Regierer AC; Strangfeld A; Marschall U; Callhoff J
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894195
[TBL] [Abstract][Full Text] [Related]
32. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
[TBL] [Abstract][Full Text] [Related]
33. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
[TBL] [Abstract][Full Text] [Related]
34. Opioid Analgesics and the Risk of Serious Infections Among Patients With Rheumatoid Arthritis: A Self-Controlled Case Series Study.
Wiese AD; Griffin MR; Stein CM; Mitchel EF; Grijalva CG
Arthritis Rheumatol; 2016 Feb; 68(2):323-31. PubMed ID: 26473742
[TBL] [Abstract][Full Text] [Related]
35. The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study.
Heiberg MS; Koldingsnes W; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2008 Feb; 59(2):234-40. PubMed ID: 18240258
[TBL] [Abstract][Full Text] [Related]
36. Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.
Girolomoni G; Altomare G; Ayala F; Berardesca E; Calzavara-Pinton P; Chimenti S; Peserico A; Puglisi Guerra A; Vena GA
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):548-60. PubMed ID: 22296031
[TBL] [Abstract][Full Text] [Related]
37. Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study.
Eun Y; Hwang J; Seo GH; Ahn JK
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36958767
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Gülfe A; Saxne T; Geborek P
Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
[TBL] [Abstract][Full Text] [Related]
39. Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.
Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LT; Petersson IF
Ann Rheum Dis; 2013 Oct; 72(10):1675-9. PubMed ID: 23148309
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study.
Ernste FC; Sánchez-Menéndez M; Wilton KM; Crowson CS; Matteson EL; Maradit Kremers H
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1015-21. PubMed ID: 25581120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
